This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents. Top assignee: Inxmed (Nanjing) Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Ping Zhang - Innovator in Tumor Treatment
Introduction
Ping Zhang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of medicine, particularly in the treatment of tumors. His innovative approach combines existing therapies to enhance treatment efficacy.
Latest Patents
Ping Zhang holds a patent for a drug combination aimed at treating tumors. The patent, titled "Drug combination and use for treating tumors," focuses on the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor. This combination is designed to improve treatment outcomes for patients suffering from tumors.
Career Highlights
Ping Zhang is associated with Inxmed (Nanjing) Co., Ltd., where he continues to work on groundbreaking medical innovations. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Ping Zhang collaborates with esteemed colleagues, including Baoyuan Zhang and Xuebin Liu. Their combined expertise fosters a productive environment for innovation and advancement in cancer treatment.
Conclusion
Ping Zhang's contributions to tumor treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile